KUALA LUMPUR: Pharmaniaga Bhd, a frontrunner to secure the government's contract to repackage and distribute the Covid-19 vaccine, said it will not be making substantial investment for the vaccine which will be bottled at its plant in Puchong.
The company's acting managing director Mohamed Iqbal Abdul Rahman said the investment for the fill and finish process for the vaccine would be around RM2mil. He added it is suitable to be bottled at its facility in Puchong as it is a sterile liquid injection plant.
"There has to be a sterile environment for the vaccine to be bottled. We already have it, and can bottle the Covid-19 vaccine immediately once the vaccine is ready.Our capacity is around 10 million doses per month on 10 doses vial.
"In my opinion, I expect the vaccine to be available either by the first or second quarter of next year as it is in clinical trial in some countries. Most of the potential vaccine developers said the vaccine would be ready by year-end, he added at a press briefing.